# NSN 6505-00-809-0241: Docusate Sodium Capsules

NSN 6505-00-809-0241 (also written 6505008090241; NIIN 00-809-0241) is a docusate sodium capsules in Federal Supply Class 6505, Drugs and Biologicals. 3 manufacturer part numbers from 3 suppliers are on record. It was last purchased in Sep 2026.

## Identification

- NSN: 6505-00-809-0241 (6505008090241)
- NIIN: 00-809-0241 (008090241)
- Item name: DOCUSATE SODIUM CAPSULES
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC Z: a commercial, nondevelopmental or off-the-shelf item. (observed 2026-10-10)
- Acquisition method code: 3

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DOCUSATE SODIUM CAPSULES USP 100MG 1000S BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT 100.000 |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| 00904788980 | 0SYT3 | MAJOR PHARMACEUTICALS INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC10135-0111-10 | 1TAP7 | MARLEX PHARMACEUTICALS INC DBA MARLEX PHARMACEUTICALS I | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC57896040110 | 06WD3 | GERI-CARE PHARMACEUTICALS CORP. | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-09-24 | [SPE2DX25D9900/SPE2DP26F012U](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008090241) | DOCUSATE SODIUM CAPSULES | DMS PHARMACEUTICAL GROUP INC | $67.38 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F006M](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008090241) | DOCUSATE SODIUM CAPSULES | DMS PHARMACEUTICAL GROUP INC | $11.23 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505008090241&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008090241
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-00-809-0241/
JSON: https://nsnexplorer.com/api/nsn/6505-00-809-0241.json